4.3 Fluid, Electrolyte, and Acid-Base Balance

4.3 Fluid, Electrolyte, and Acid-Base Balance

Fluid, electrolyte, and acid-base homeostasis is vital for cellular metabolism, neuromuscular transmission, cardiac electrophysiology, and tissue perfusion. Registered nurses must understand fluid shifts across semipermeable cellular membranes, systematically interpret arterial blood gases, and rapidly recognize and intervene in life-threatening electrolyte disturbances.

---

Tonicity and Intravenous Fluid Dynamics

Normal human serum osmolality ranges from 275 to 295 mOsm/kg. The movement of water between the intracellular fluid (ICF) and extracellular fluid (ECF) compartments is dictated by osmotic gradients across the semipermeable cell membrane. Intravenous crystalloid solutions are classified into three distinct categories based on their tonicity relative to plasma.

---

Step-by-Step Arterial Blood Gas (ABG) Analysis

Arterial blood gas assessment provides real-time information regarding systemic oxygenation, alveolar ventilation, and acid-base homeostasis. Systematic interpretation follows four clear clinical steps.

Normal Adult Arterial Blood Gas Reference Ranges

• pH: $7.35 - 7.45$ (Neutral balance point is exactly 7.40)
• $\text{PaCO}_2$: $35 - 45\text{ mmHg}$ (Respiratory component: acidic carbon dioxide regulated by lungs)
• $\text{HCO}_3^-$: $22 - 26\text{ mEq/L}$ (Metabolic component: basic bicarbonate regulated by kidneys)
• $\text{PaO}_2$: $80 - 100\text{ mmHg}$ (Partial pressure of arterial oxygen)
• $\text{SaO}_2$: $95 - 100%$ (Arterial oxygen saturation)

The 4-Step ABG Interpretation Method

1. Step 1: Evaluate the pH.
   • $\text{pH} < 7.35 = \text{Acidosis}$
   • $\text{pH} > 7.45 = \text{Alkalosis}$
   • $\text{pH} = 7.35 - 7.45 = \text{Normal (or Fully Compensated)}$
2. Step 2: Evaluate the Respiratory Parameter ($\text{PaCO}_2$).
   • $\text{PaCO}_2 > 45\text{ mmHg} = \text{Respiratory Acidosis}$ (hypoventilation, $\text{CO}_2$ retention)
   • $\text{PaCO}_2 < 35\text{ mmHg} = \text{Respiratory Alkalosis}$ (hyperventilation, $\text{CO}_2$ blowout)
3. Step 3: Evaluate the Metabolic Parameter ($\text{HCO}_3^-$).
   • $\text{HCO}_3^- < 22\text{ mEq/L} = \text{Metabolic Acidosis}$ (base deficit or acid accumulation)
   • $\text{HCO}_3^- > 26\text{ mEq/L} = \text{Metabolic Alkalosis}$ (excess base or acid loss)
4. Step 4: Determine the Primary Etiology and Degree of Compensation.
   • Apply the ROME mnemonic:
     • Respiratory Opposite: When the primary disorder is respiratory, pH and $\text{PaCO}_2$ move in opposite directions (e.g., $\text{pH} \downarrow$ and $\text{PaCO}_2 \uparrow$).
     • Metabolic Equal: When the primary disorder is metabolic, pH and $\text{HCO}_3^-$ move in the same direction (e.g., $\text{pH} \downarrow$ and $\text{HCO}_3^- \downarrow$).
   • Classify the Compensatory State:
     • Uncompensated: pH is abnormal. One parameter ($\text{PaCO}_2$ or $\text{HCO}_3^-$) is abnormal (causing the primary disturbance), while the opposing parameter remains completely within normal limits.
     • Partially Compensated: pH is abnormal. Both $\text{PaCO}_2$ and $\text{HCO}_3^-$ are abnormal, moving in the same direction as the opposing system attempts to buffer the disturbance, but has not yet restored pH to normal.
     • Fully Compensated: pH is within normal limits ($7.35 - 7.45$). Both $\text{PaCO}_2$ and $\text{HCO}_3^-$ are abnormal. Look at the pH relative to the 7.40 midpoint: a pH of 7.35–7.39 indicates a compensated primary acidosis; a pH of 7.41–7.45 indicates a compensated primary alkalosis.

Clinical Etiologies of Acid-Base Disturbances

---

Major Electrolyte Imbalances

Electrolytes maintain cellular electrical neutrality, osmotic pressure, and action potential propagation across nervous and muscular tissues.

1. Potassium Balance (Normal Range: 3.5 to 5.0 mEq/L)

Potassium is the major intracellular cation. Small fluctuations in extracellular potassium alter resting membrane potential, with profound cardiac electrophysiological consequences.

• Hypokalemia (<3.5 mEq/L):
  • Causes: Potassium-wasting loop/thiazide diuretics (furosemide), gastrointestinal losses (vomiting, NG suction, diarrhea), hyperaldosteronism, intracellular shifts from insulin administration or alkalosis.
  • Clinical Manifestations: Muscle weakness, cramping, hyporeflexia, constipation, paralytic ileus, paresthesias.
  • ECG Changes: Flattened or inverted T waves, prominent U waves, ST-segment depression, and increased risk of ventricular ectopy and digoxin toxicity.
  • Management: Oral replacement for mild deficits (give with food to prevent mucosal irritation). Intravenous potassium chloride for severe deficits: NEVER give IV push. Maximum peripheral infusion rate is 10 mEq/hr; maximum central line infusion rate is 20 mEq/hr with continuous ECG telemetry monitoring.
• Hyperkalemia (>5.0 mEq/L):
  • Causes: Renal failure (AKI/CKD), severe tissue trauma/crush injuries, burns, potassium-sparing diuretics (spironolactone), ACE inhibitors, metabolic acidosis.
  • Clinical Manifestations: Muscle twitching, paresthesias progressing to flaccid paralysis, abdominal cramping, hyperactive bowel sounds.
  • ECG Changes: Tall, peaked T waves, prolonged PR interval, widening of the QRS complex, loss of P waves, progressing to sine waves, ventricular fibrillation, and asystole.
  • Emergency 3-Step Management Protocol:
    1. Myocardial Membrane Stabilization: Administer intravenous calcium gluconate (10 mL of 10% solution over 2 to 3 minutes). Calcium does not lower serum potassium; it directly elevates myocardial threshold potential, protecting against lethal dysrhythmias.
    2. Intracellular Shifting: Administer 10 units of IV Regular Insulin along with 50 mL of 50% Dextrose (D50W) to shift potassium into cells (dextrose prevents hypoglycemia). Nebulized albuterol and IV sodium bicarbonate provide additional shifting.
    3. Elimination from Body: Administer sodium polystyrene sulfonate (Kayexalate) or patiromer to bind potassium in the GI tract; administer IV loop diuretics (furosemide) if renal function is intact; prepare for emergent hemodialysis in refractory cases or anuric renal failure.

2. Sodium Balance (Normal Range: 135 to 145 mEq/L)

Sodium is the predominant extracellular cation, regulating plasma osmolality and fluid distribution between vascular and cellular spaces.

• Hyponatremia (<135 mEq/L):
  • Pathophysiology: Hypoosmolality causes water to shift into cells, producing cellular swelling and cerebral edema.
  • Causes: Syndrome of Inappropriate Antidiuretic Hormone (SIADH), excessive hypotonic IV fluid administration, congestive heart failure, cirrhosis, diuretic therapy.
  • Clinical Manifestations: Headache, lethargy, confusion, nausea, vomiting, muscle cramps; severe levels (<120 mEq/L) produce seizures, coma, and tentorial brain herniation.
  • Management: Fluid restriction for euvolemic/hypervolemic hyponatremia; 0.9% normal saline for hypovolemic hyponatremia. For severe acute neurological emergencies (seizures), infuse 3% hypertonic saline via central line under intensive care monitoring. Safety Alert: Never correct sodium faster than 8 to 10 mEq/L in a 24-hour period, as rapid demyelination of brainstem neurons produces irreversible osmotic demyelination syndrome (central pontine myelinolysis).
• Hypernatremia (>145 mEq/L):
  • Pathophysiology: Hyperosmolality draws water out of cells into the vascular bed, producing cellular dehydration and brain shrinkage.
  • Causes: Diabetes insipidus (inadequate ADH), profuse diaphoresis, unreplaced insensible fluid losses, osmotic diuresis, hypertonic enteral feedings.
  • Clinical Manifestations: Intense thirst, dry sticky mucous membranes, flushed skin, hyperreflexia, restlessness, agitation, tachycardia.
  • Management: Gradual rehydration with oral water or hypotonic IV solutions (0.45% NS, D5W). Correct slowly over 48 hours to prevent rebound cerebral edema.

3. Calcium Balance (Normal Range: 8.5 to 10.5 mg/dL)

Regulated by parathyroid hormone (PTH), calcitonin, and vitamin D. Calcium controls neuromuscular excitability, cardiac contractility, and bone integrity.

• Hypocalcemia (<8.5 mg/dL):
  • Causes: Hypoparathyroidism (accidental surgical excision during thyroidectomy), acute pancreatitis, vitamin D deficiency, end-stage renal disease, massive blood transfusions (citrate preservative binds ionized calcium).
  • Clinical Manifestations: Neuromuscular hyperexcitability, perioral paresthesias, numbness/tingling in fingers and toes, painful muscle cramps, laryngospasm, seizures, and prolonged QT intervals on ECG (predisposing to Torsades de Pointes).
  • Diagnostic Physical Signs:
    • Chvostek's Sign: Tapping the facial nerve anterior to the earlobe produces involuntary ipsilateral twitching of facial muscles (corner of mouth and cheek).
    • Trousseau's Sign: Inflating a blood pressure cuff above the patient's systolic pressure for 3 minutes produces painful carpopedal spasm (wrist and metacarpophalangeal flexion with interphalangeal extension).
  • Management: Administer IV calcium gluconate slowly under cardiac monitoring. Provide oral calcium carbonate with active vitamin D (calcitriol) for chronic maintenance.
• Hypercalcemia (>10.5 mg/dL):
  • Causes: Primary hyperparathyroidism, osteolytic bone malignancies, thiazide diuretics, excessive vitamin D intake.
  • Clinical Manifestations: Neuromuscular depression summarized as "stones, bones, groans, thrones, and psychiatric overtones" (nephrolithiasis, bone pain/pathologic fractures, abdominal pain/constipation, polyuria, lethargy/confusion). ECG reveals shortened QT interval.
  • Management: Aggressive IV hydration with 0.9% normal saline (300–500 mL/hr initially) to promote renal calcium excretion, followed by IV loop diuretics (furosemide). Administer IV bisphosphonates (zoledronic acid) and calcitonin for oncological hypercalcemia.

4. Magnesium Balance (Normal Range: 1.5 to 2.5 mg/dL)

Magnesium is an essential intracellular cofactor for over 300 enzymatic reactions, including the sodium-potassium ATPase pump and neuromuscular conduction.

• Hypomagnesemia (<1.5 mg/dL):
  • Causes: Chronic alcohol use disorder, malnutrition, malabsorption syndromes, prolonged nasogastric suction, loop diuretics.
  • Manifestations: Hyperactive deep tendon reflexes (DTRs), tremors, tetany, positive Chvostek's and Trousseau's signs, nystagmus, cardiac dysrhythmias (Torsades de Pointes). Often accompanied by refractory hypokalemia and hypocalcemia.
  • Management: Infuse IV magnesium sulfate slowly (maximum 1 to 2 grams over 1 hour, except in emergency cardiac arrest or eclamptic seizures). Continuously assess deep tendon reflexes and respiratory rate.
• Hypermagnesemia (>2.5 mg/dL):
  • Causes: Renal insufficiency combined with magnesium-containing antacids/laxatives, excessive IV magnesium sulfate infusion for preeclampsia.
  • Manifestations: Neuromuscular and central nervous system depression. Loss or diminishment of deep tendon reflexes (DTRs) is the earliest warning sign (at 4–6 mg/dL). Progression leads to severe bradycardia, hypotension, respiratory depression, and cardiac arrest (>15 mg/dL).
  • Antidote: Intravenous Calcium Gluconate directly antagonizes the toxic neuromuscular and cardiac effects of hypermagnesemia.